Journal article
Erratum: Cost Effectiveness of Apixaban Versus Aspirin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation in Belgium [Clin Drug Investig, DOI 10.1007/s40261-014-0224-z]
T Kongnakorn, T Lanitis, L Annemans, V Thijs, S Marbaix
Clinical Drug Investigation | ADIS INT LTD | Published : 2014